Microtiter plate assays, a high throughput solution

The innovative biomarkers are available as CE-IVD microtiter plate assays

The microtiter plate is a standard tool in analytical research and diagnostic testing laboratories. SphingoTec’s microtiter plate assays are based on a chemiluminescence sandwich immunoassay technology and allow the measurement of SphingoTec’s proprietary biomarkers Proenkephalin A 119-159 (penKid) and bioactive Adrenomedullin 1-52 (bio-ADM). They are available as CE IVD microtiter plate assays. In addition, SphingoTec offers CE IVD microtiter plate assays for the novel biomarker Dipeptidyl Peptidase 3 (DPP3).

EDTA plasma

sphingotest® microtiter plate assay requires EDTA plasma

1h incubation

Following a 30-minute hands-on time, the assay incubates for 1 hour

High throughput

96 well plate test kit contains enough reagent to run 41 samples in double determinations

Critical care diagnostics

sphingotest® penKid®

CE₀₁₂₃ IVD

sphingotest^® penKid^®is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of Proenkephalin A 119-159 in human EDTA plasma.

Proenkephalin A 119-159 measurement, in conjunction with clinical assessments and other laboratory findings, is used as an aid in the diagnosis of acute kidney injury (AKI) in adult patients with sepsis or septic shock.

sphingotest® bio-ADM®

CE IVD

The sphingotest^® bio-ADM^® is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of bioactive Adrenomedullin 1-52 in human EDTA plasma.

Bioactive Adrenomedullin 1-52 measurement in conjunction with clinical assessments and other laboratory findings is used as an aid in the prediction of the need of vasopressor therapy in patients with sepsis or septic shock.

sphingotest® DPP3

CE IVD

The sphingotest^® DPP3 is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of dipeptidyl peptidase 3 in human EDTA plasma.

Dipeptidyl peptidase 3 (DPP3) measurement in conjunction with clinical assessments and other laboratory findings is used as an aid in the prediction of short-term survival in patients with sepsis or septic shock.

sphingotest® Lightning

CE IVD

The sphingotest^® Lightning is a reagent intended for quantitative in vitro diagnostics and used for automated chemiluminescence measurement of sphingotest® immunoluminometric assays (ILMA) using acridinium ester technology in conjunction with an automated flash-type luminometer.